p53 isoforms can regulate p53 transcriptional activity

Antibodies, a laboratory manual

(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318 · see citing works

T antigen is bound to a host protein in SY40-transformed cells

Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,443 · see citing works

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814 · see citing works

p53 mutant mice that display early ageing-associated phenotypes

Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · see citing works

Decision making by p53: life, death and cancer

Oren, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,063 · see citing works

Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

DeLeo, A. B., Jay, G. D., Appella, E., DuBois, G. C., Law, L. W., & Old, L. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2420 · Cited by 721 · see citing works

Modulation of mammalian life span by the short isoform of p53

Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M., & Scrable, H. (2004) · Genes & Development · doi:10.1101/gad.1162404 · Cited by 586 · see citing works

Mdm2-Mediated NEDD8 Conjugation of p53 Inhibits Its Transcriptional Activity

Xirodimas, D. P., Saville, M. K., Bourdon, J.-C., Hay, R. T., & Lane, D. P. (2004) · Cell · doi:10.1016/j.cell.2004.06.016 · Cited by 570 · see citing works

On the shoulders of giants: p63, p73 and the rise of p53

Yang, A., Kaghad, M., Caput, D., & McKeon, F. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02595-7 · Cited by 486 · see citing works

Drosophila p53 Binds a Damage Response Element at the reaper Locus

Brodsky, M. H., Nordstrom, W., Tsang, G., Kwan, E., Rubin, G. M., & Abrams, J. (2000) · Cell · doi:10.1016/s0092-8674(00)80627-3 · Cited by 467 · see citing works

Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53

Ollmann, M. M., Young, L. M., Como, C. J. D., Karim, F. D., Belvin, M. P., Robertson, S., Whittaker, K. L., Demsky, M., Fisher, W. W., Buchman, A. R., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80626-1 · Cited by 413 · see citing works

Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum

Kress, M., May, E., Cassingena, R., & May, P. (1979) · Journal of Virology · doi:10.1128/jvi.31.2.472-483.1979 · Cited by 359 · see citing works

Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo

Kaeser, M., & Iggo, R. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.012283399 · Cited by 346 · see citing works

Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli

Midgley, C., Fisher, C., Bártek, J., Vojtěšek, B., Lane, D. P., & Barnes, D. M. (1992) · Journal of Cell Science · doi:10.1242/jcs.101.1.183 · Cited by 330 · see citing works

Characterization of the Human p53 Gene

Lamb, P., & Crawford, L. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1379 · Cited by 328 · see citing works

p53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products

Yin, Y., Stephen, C. W., Luciani, M. G., & Fåhræus, R. (2002) · Nature Cell Biology · doi:10.1038/ncb801 · Cited by 305 · see citing works

p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes

Dohn, M. R., Zhang, S., & Chen, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204427 · Cited by 294 · see citing works

Functional regulation of p73 and p63: development and cancer

Melino, G. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.10.004 · Cited by 277 · see citing works

ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53

Courtois-Cox, S., Verhaegh, G. W. C. T., North, S., Luciani, M. G., Lassus, P., Hibner, U., Oren, M., & Hainaut, P. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205874 · Cited by 264 · see citing works

The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor

Bates, G. J., Nicol, S. M., Wilson, B. J., Jacobs, A.-M. F., Bourdon, J., Wardrop, J., Gregory, D. J., Lane, D. P., Perkins, N. D., & Fuller-Pace, F. V. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600550 · Cited by 232 · see citing works

DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.

Wu, G., Nomoto, S., Hoque, M. O., Dracheva, T., Osada, M., Lee, C. R., Dong, S. M., Guo, Z., Benoit, N. E., Cohen, Y., et al. (2003) · PubMed · Cited by 221 · see citing works

Regulation of Human p53 Activity and Cell Localization by Alternative Splicing

Ghosh, A., Stewart, D., & Matlashewski, G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.7987-7997.2004 · Cited by 221 · see citing works

Identification and characterization of a p53 homologue in Drosophila melanogaster

Jin, S. V., Martinek, S., Joo, W. S., Wortman, J. R., Mirković, N., Šali, A., Yandell, M. D., Pavletich, N. P., Young, M. W., & Levine, A. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7301 · Cited by 219 · see citing works

TP53 family members and human cancers

Bénard, J., Douc‐Rasy, S., & Ahomadegbe, J. (2003) · Human Mutation · doi:10.1002/humu.10172 · Cited by 205 · see citing works

Characterisation of Epitopes on Human p53 using Phage-displayed Peptide Libraries: Insights into Antibody-Peptide Interactions

Stephen, C. W., Helminen, P., & Lane, D. P. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0202 · Cited by 180 · see citing works

Identification of a Novel p53 Functional Domain That Is Necessary for Mediating Apoptosis

Zhu, J., Zhou, W., Jiang, J., & Chen, X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13030 · Cited by 167 · see citing works

Identification of new polypeptide species (48–55K) immunoprecipitable by antiserum to purified large T antigen and present in SV40-infected and -transformed cells

Melero, J. A., Stitt, D. T., Mangel, W. F., & Carroll, R. B. (1979) · Virology · doi:10.1016/0042-6822(79)90250-2 · Cited by 162 · see citing works

Arrangement of specific oligonucleotides within poly(A) terminated HnRNA molecules

Molloy, G. R., Jelinek, W. R., Salditt-Georgieff, M., & Darnell, J. E., Jr. (1974) · Cell · doi:10.1016/0092-8674(74)90154-8 · Cited by 158 · see citing works

The 5′ region of the p53 gene: evolutionary conservation and evidence for a negative regulatory element.

Bienz-Tadmor, B., Zakut, R., Libresco, S. M., Givol, D., & Oren, M. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04067.x · Cited by 134 · see citing works

Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membrane

Bourdon, J., Renzing, J., Robertson, P., Fernandes, K., & Lane, D. P. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200203006 · Cited by 122 · see citing works

The C Terminus of p53 Family Proteins Is a Cell Fate Determinant

Harms, K. L., & Chen, X. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.5.2014-2030.2005 · Cited by 108 · see citing works

Definition of the p53 Functional Domains Necessary for Inducing Apoptosis

Zhu, J., Zhang, S., Jiang, J., & Chen, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005676200 · Cited by 104 · see citing works

ΔNp73β Is Active in Transactivation and Growth Suppression

Liu, G., Nozell, S. E., Xiao, H., & Chen, X. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.487-501.2004 · Cited by 104 · see citing works

The human tumour suppressor gene p53 is alternatively spliced in normal cells.

Flaman, J., Waridel, F., Estreicher, A., Vannier, A., Limacher, J., Gilbert, D., Iggo, R. D., & Frébourg, T. (1996) · PubMed · Cited by 98 · see citing works

Isolation of a Full-Length Mouse cDNA Clone Coding for an Immunologically Distinct p53 Molecule

Wolf, D., Harris, N., Goldfinger, N., & Rotter, V. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.1.127 · Cited by 83 · see citing works

Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein.

Vojtěšek, B., Dolezalova, H., Lauerová, L., Svitáková, M., Havlis, P., Kovařík, J., Midgley, C. A., & Lane, D. P. (1995) · PubMed · Cited by 72 · see citing works

p53-dependent growth arrest following calcium phosphate-mediated transfection of murine fibroblasts.

Renzing, J., & Lane, D. P. (1995) · PubMed · Cited by 71 · see citing works

Wild‐type alternatively spliced p53: binding to DNA and interaction with the major p53 protein in vitro and in cells.

Wu, Y., Liu, Y., Lee, L., Miner, Z., & Kulesz-Martin, M. F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06808.x · Cited by 52 · see citing works

Isolation of a Full-Length Mouse cDNA Clone Coding for an Immunologically Distinct p53 Molecule

Wolf, D., Harris, N. L., Goldfinger, N., et al. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.1.127-132.1985 · Cited by 44 · see citing works

Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein

Liu, W.-L., Midgley, C., Stephen, C. W., Saville, M. K., & Lane, D. P. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5082 · Cited by 38 · see citing works

p53-dependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53

Almog, N., Goldfinger, N., & Rotter, V. (2000) · Oncogene · doi:10.1038/sj.onc.1203673 · Cited by 34 · see citing works

Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis

Chambon, V., Vacher, M., Jullien, M., May, E., & Bourdon, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203960 · Cited by 28 · see citing works

The neurogene BTG2TIS21/PC3 is transactivated by ΔNp73α via p53 specifically in neuroblastoma cells

Goldschneider, D., Million, K., Meiller, A., Haddada, H., Puisieux, A., Bénard, J., May, E., & Douc‐Rasy, S. (2005) · Journal of Cell Science · doi:10.1242/jcs.01704 · Cited by 18 · see citing works

Blinded by the Light: The Growing Complexity of p53

Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · see citing works

p53 in health and disease

Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,275 · see citing works

The first 30 years of p53: growing ever more complex.

Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967 · see citing works

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286 · see citing works

Targeting p53 pathways: mechanisms, structures, and advances in therapy

Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016 · see citing works

p53 Activation by Knockdown Technologies

Robu, M. E., Larson, J. D., Nasevicius, A., Beiraghi, S., Brenner, C., Farber, S. A., & Ekker, S. C. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0030078 · Cited by 1,018 · see citing works

Function and structure of inherently disordered proteins

Dunker, A. K., Silman, I., Uversky, V. N., & Sussman, J. L. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.10.002 · Cited by 963 · see citing works

p53 ubiquitination: Mdm2 and beyond

Brooks, C. L., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.020 · Cited by 924 · see citing works

Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting

Borrero, L. J. H., & El‐Deiry, W. S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188556 · Cited by 773 · see citing works

Role of p53 in Cell Death and Human Cancers

Ozaki, T., & Nakagawara, A. (2011) · Cancers · doi:10.3390/cancers3010994 · Cited by 743 · see citing works

The P53 pathway: what questions remain to be explored?

Levine, A. J., Hu, W., & Feng, Z. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401910 · Cited by 654 · see citing works

The expanding universe of p53 targets

Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2730 · Cited by 568 · see citing works

Transcriptional Regulation by P53

Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569 · see citing works

p63 protects the female germ line during meiotic arrest

Suh, E.-K., Yang, A., Kettenbach, A. N., Bamberger, C., Michaelis, A. H., Zhu, Z., Elvin, J. A., Bronson, R. T., Crum, C. P., & McKeon, F. (2006) · Nature · doi:10.1038/nature05337 · Cited by 550 · see citing works

p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress

Murray-Zmijewski, F., Lane, D. P., & Bourdon, J. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401914 · Cited by 524 · see citing works

Transcriptional regulation by p53: one protein, many possibilities

Laptenko, O., & Prives, C. L. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401916 · Cited by 500 · see citing works

Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)

Theillet, F., Binolfi, A., Frembgen-Kesner, T., Hingorani, K. S., Sarkar, M., Kyne, C., Li, C., Crowley, P. B., Gierasch, L. M., Pielak, G. J., et al. (2014) · Chemical Reviews · doi:10.1021/cr400695p · Cited by 504 · see citing works

Genome-wide prediction of disease variant effects with a deep protein language model

Brandes, N., Goldman, G., Wang, C. H., Ye, C., & Ntranos, V. (2023) · Nature Genetics · doi:10.1038/s41588-023-01465-0 · Cited by 459 · see citing works

TAp73 knockout shows genomic instability with infertility and tumor suppressor functionsPreprint

Tomasini, R., Tsuchihara, K., Wilhelm, M., Fujitani, M., Rufini, A., Cheung, C. C., Khan, F., Itie-YouTen, A., Wakeham, A. C., Tsao, M., et al. (2008) · Genes & Development · doi:10.1101/gad.1695308 · Cited by 429 · see citing works

Structural Basis of DNA Recognition by p53 Tetramers

Kitayner, M., Rozenberg, H., Kessler, N., Rabinovich, D., Shaulov, L., Haran, T. E., & Shakked, Z. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.015 · Cited by 408 · see citing works

The role of mutant p53 in human cancer

Goh, A. M., Coffill, C. R., & Lane, D. P. (2010) · The Journal of Pathology · doi:10.1002/path.2784 · Cited by 398 · see citing works

Two faces of p53: aging and tumor suppression

Rodier, F., Campisi, J., & Bhaumik, D. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm744 · Cited by 399 · see citing works

Clinical Outcomes and Correlates of TP53 Mutations and CancerPreprint

Robles, A. I., & Harris, C. C. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001016 · Cited by 394 · see citing works

Uncovering the role of p53 splice variants in human malignancy: a clinical perspective

Bourdon, J., Surget, S., & Khoury, M. P. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s53876 · Cited by 380 · see citing works

p53 and breast cancer, an update

Lacroix, M., Toillon, R., & Leclercq, G. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01172 · Cited by 380 · see citing works

Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm

Soussi, T., & Wiman, K. G. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.001 · Cited by 366 · see citing works

Mutant p53 as a target for cancer treatment

Duffy, M. J., Synnott, N. C., & Crown, J. P. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.06.023 · Cited by 361 · see citing works

p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence

Fujita, K., Mondal, A. M., Horikawa, I., Nguyen, G. H., Kumamoto, K., Sohn, J. J., Bowman, E. D., Mathe, E. A., Schetter, A. J., Pine, S. R., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1928 · Cited by 336 · see citing works

The connection between splicing and cancer

Srebrow, A., & Kornblihtt, A. R. (2006) · Journal of Cell Science · doi:10.1242/jcs.03053 · Cited by 335 · see citing works

p63 and p73, the ancestors of p53

Dotsch, V., Bernassola, F., Coutandin, D., Candi, E., & Melino, G. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004887 · Cited by 326 · see citing works

The p53 family and programmed cell death

Pietsch, E. C., Sykes, S. M., McMahon, S. B., & Murphy, M. E. (2008) · Oncogene · doi:10.1038/onc.2008.315 · Cited by 314 · see citing works

The p53 family in differentiation and tumorigenesis

Stiewe, T. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2072 · Cited by 306 · see citing works

Alternative splicing in cancer: implications for biology and therapy

Chen, J., & Weiss, W. A. (2014) · Oncogene · doi:10.1038/onc.2013.570 · Cited by 304 · see citing works

p63 deficiency activates a program of cellular senescence and leads to accelerated agingPreprint

Keyes, W. M., Wu, Y., Vogel, H. S., Guo, X., Lowe, S. W., & Mills, A. A. (2005) · Genes & Development · doi:10.1101/gad.342305 · Cited by 296 · see citing works

The Origins and Evolution of the p53 Family of GenesPreprint

Белый, В. А., Ak, P., Markert, E. K., Wang, H., Hu, W., Puzio‐Kuter, A. M., & Levine, A. J. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001198 · Cited by 293 · see citing works

p53 Family and Cellular Stress Responses in Cancer

Pflaum, J., Schlosser, S., & ller, M. M. ⁄. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00285 · Cited by 294 · see citing works

The rebel angel: mutant p53 as the driving oncogene in breast cancer

Walerych, D., Napoli, M., Collavin, L., & Sal, G. D. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs232 · Cited by 287 · see citing works

p63 and p73 in human cancer: defining the network

DeYoung, M. P., & Ellisen, L. W. (2007) · Oncogene · doi:10.1038/sj.onc.1210337 · Cited by 261 · see citing works

Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines

Liu, Y., & Bodmer, W. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510146103 · Cited by 257 · see citing works

p53 and its isoforms in cancer

Bourdon, J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603886 · Cited by 245 · see citing works

Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment

Leroy, B., Girard, L., Hollestelle, A., Minna, J. D., Gazdar, A. F., & Soussi, T. (2014) · Human Mutation · doi:10.1002/humu.22556 · Cited by 224 · see citing works

RNA Splicing and Cancer

Wang, E., & Aifantis, I. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.04.011 · Cited by 242 · see citing works

G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms

Marcel, V., Tran, P. L. T., Sagne, C., Martel‐Planche, G., Vaslin, L., Teulade‐Fichou, M., Hall, J. A., Mergny, J., Hainaut, P. L., & Dyck, E. V. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq253 · Cited by 241 · see citing works

p53 alterations in human cancer: more questions than answers

Soussi, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210280 · Cited by 232 · see citing works

Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations

Bosse, K. R., & Maris, J. M. (2015) · Cancer · doi:10.1002/cncr.29706 · Cited by 220 · see citing works

Tumor suppression and normal aging in mice with constitutively high p53 activity

Mendrysa, S. M., O'Leary, K. A., McElwee, M. K., Michalowski, J., Eisenman, R. N., Powell, D. A., & Perry, M. E. (2006) · Genes & Development · doi:10.1101/gad.1378506 · Cited by 210 · see citing works

Autophagy and the Cell Cycle: A Complex Landscape

Mathiassen, S. G., Zio, D. D., & Cecconi, F. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00051 · Cited by 210 · see citing works

Tumour suppression by p53: the importance of apoptosis and cellular senescence

Zuckerman, V., Wolyniec, K., Sionov, R. V., Haupt, S., & Haupt, Y. (2009) · The Journal of Pathology · doi:10.1002/path.2584 · Cited by 210 · see citing works

Biological functions of p53 isoforms through evolution: lessons from animal and cellular models

Marcel, V., Dichtel-Danjoy, M.-L., Sagne, C., Hafsi, H., Ma, D., Ortiz‐Cuaran, S., Olivier, M., Hall, J. A., Mollereau, B., Hainaut, P. L., et al. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.120 · Cited by 210 · see citing works

p53: The Janus of autophagy?

Levine, B., & Abrams, J. (2008) · Nature Cell Biology · doi:10.1038/ncb0608-637 · Cited by 206 · see citing works

Compensatory Proliferation in Drosophila Imaginal Discs Requires Dronc-Dependent p53 Activity

Wells, B. S., Yoshida, E., & Johnston, L. A. (2006) · Current Biology · doi:10.1016/j.cub.2006.07.046 · Cited by 206 · see citing works

The pathophysiological role of mitochondrial oxidative stress in lung diseases

Liu, X., & Chen, Z. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1306-5 · Cited by 202 · see citing works

How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?

Olsson, A., Manzl, C., Strasser, A., & Villunger, A. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402196 · Cited by 200 · see citing works

The Isoforms of the p53 Protein

Khoury, M. P., & Bourdon, J.-C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000927 · Cited by 191 · see citing works

p53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure–Function Continuum Concept

Uversky, V. N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111874 · Cited by 193 · see citing works

p53 Isoforms: Key Regulators of the Cell Fate DecisionPreprint

Joruiz, S. M., & Bourdon, J. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026039 · Cited by 191 · see citing works

Crosstalk of Notch with p53 and p63 in cancer growth control

Dotto, G. P. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2675 · Cited by 189 · see citing works

Aberrant Alternative Splicing Is Another Hallmark of Cancer

Ladomery, M. (2013) · International Journal of Cell Biology · doi:10.1155/2013/463786 · Cited by 176 · see citing works

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies

Xu-Monette, Z. Y., Medeiros, L. J., Li, Y., Orlowski, R. Z., Andreeff, M., Bueso-Ramos, C., Greiner, T. C., McDonnell, T. J., & Young, K. H. (2012) · Blood · doi:10.1182/blood-2011-11-366062 · Cited by 179 · see citing works

The role of the p53 tumor suppressor in metabolism and diabetes

Kung, C.-P., & Murphy, M. E. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0324 · Cited by 177 · see citing works

Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer

Sebestyén, E., Zawisza-Álvarez, M., & Eyras, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1392 · Cited by 173 · see citing works

MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma

Jin, L., Hu, W. L., Jiang, C. C., Wang, J. X., Han, C. C., Chu, P., Zhang, L. J., Thorne, R. F., Wilmott, J. S., Scolyer, R. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019312108 · Cited by 176 · see citing works

p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration

Turnquist, C., Horikawa, I., Foran, E., Major, E. O., Vojtěšek, B., Lane, D. P., Lü, X., Harris, B. T., & Harris, C. C. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.37 · Cited by 177 · see citing works

Endoplasmic Reticulum Stress Induces G2 Cell-Cycle Arrest via mRNA Translation of the p53 Isoform p53/47

Bourougaa, K., Naski, N., Boularan, C., Mlynarczyk, C., Candeias, M. M., Marullo, S., & Fåhræus, R. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.041 · Cited by 172 · see citing works

Senescence Regulation by the p53 Protein Family

Qian, Y., & Chen, X. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-239-1_3 · Cited by 170 · see citing works

Loss of function of def selectively up-regulates Δ113p53 expression to arrest expansion growth of digestive organs in zebrafishPreprint

Chen, J., Ruan, H., Ng, S. M. E., Gao, C., Soo, H. M., Wu, W., Zhang, Z., Wen, Z., Lane, D. P., & Peng, J. (2005) · Genes & Development · doi:10.1101/gad.1366405 · Cited by 170 · see citing works

p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes

Mondal, A. M., Horikawa, I., Pine, S. R., Fujita, K., Morgan, K. M., Vera, E., Mazur, S. J., Appella, E., Vojtesek, B., Blasco, M. A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70355 · Cited by 164 · see citing works

Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence

Tang, Y., Horikawa, I., Ajiro, M., Robles, A. I., Fujita, K., Mondal, A. M., Stauffer, J. K., Zheng, Z.-M., & Harris, C. C. (2013) · Oncogene · doi:10.1038/onc.2012.288 · Cited by 165 · see citing works

p53 Isoforms: An Intracellular Microprocessor?

Khoury, M. P., & Bourdon, J. (2011) · Genes & Cancer · doi:10.1177/1947601911408893 · Cited by 167 · see citing works

Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme

England, B., Huang, T., & Karsy, M. (2013) · Tumor Biology · doi:10.1007/s13277-013-0871-3 · Cited by 163 · see citing works

Caught in the cross fire: p53 in inflammation

Cooks, T., Harris, C. C., & Oren, M. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu134 · Cited by 160 · see citing works

Recent advances in p53 research: an interdisciplinary perspective

Olivier, M., Petitjean, A., Marcel, V., Pétré, A., Mounawar, M., Plymoth, A., de Fromentel, C. C., & Hainaut, P. L. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.69 · Cited by 161 · see citing works

Methods and biomarkers for early detection, prediction, and diagnosis of colorectal cancer

Zhang, Y., Wang, Y., Zhang, B., Li, P., & Zhao, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114786 · Cited by 162 · see citing works

Exploring the multiple roles of guardian of the genome: P53

Feroz, W., & Sheikh, A. M. A. (2020) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00089-x · Cited by 161 · see citing works

p53 isoform Δ113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafishPreprint

Chen, J., Ng, S. M. E., Chang, C., Zhang, Z., Bourdon, J., Lane, D. P., & Peng, J. (2009) · Genes & Development · doi:10.1101/gad.1761609 · Cited by 155 · see citing works

Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides

Floquet, C., Deforges, J., Rousset, J., & Bidou, L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1277 · Cited by 153 · see citing works

p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome

Spike, B. T., & Wahl, G. M. (2011) · Genes & Cancer · doi:10.1177/1947601911410224 · Cited by 150 · see citing works

Crystal Structure of the p53 Core Domain Bound to a Full Consensus Site as a Self-Assembled Tetramer

Chen, Y., Dey, R., & Chen, L. (2010) · Structure · doi:10.1016/j.str.2009.11.011 · Cited by 151 · see citing works

Co-localization of mutant p53 and amyloid-like protein aggregates in breast tumors

Levy, C. B., Stumbo, A. C., Bom, A. P. D. A., Portari, E. A., Carneiro, Y., Silva, J. L., & Gallo, C. V. D. M. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.10.017 · Cited by 150 · see citing works

Massively regulated genes: the example of TP53

Hollstein, M. C., & Hainaut, P. L. (2009) · The Journal of Pathology · doi:10.1002/path.2637 · Cited by 142 · see citing works

p53 Isoforms and Their Implications in Cancer

Vieler, M., & Sanyal, S. (2018) · Cancers · doi:10.3390/cancers10090288 · Cited by 140 · see citing works

One, two, three—p53, p63, p73 and chemosensitivity

MULLER, M., Schleithoff, E. S., Stremmel, W., Melino, G., Krammer, P. H., & Schilling, T. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2007.01.001 · Cited by 140 · see citing works

ASPPs and cancer

Trigiante, G., & Lü, X. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1818 · Cited by 133 · see citing works

Δ160p53 is a novel N‐terminal p53 isoform encoded by Δ133p53 transcript

Marcel, V., Perrier, S., Aoubala, M., Ageorges, S., Groves, M. J., Diot, A., Fernandes, K., Tauro, S., & Bourdon, J. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.005 · Cited by 132 · see citing works

p53: The Attractive Tumor Suppressor in the Cancer Research Field

Ozaki, T., & Nakagawara, A. (2010) · BioMed Research International · doi:10.1155/2011/603925 · Cited by 132 · see citing works

p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage

Aoubala, M., Murray-Zmijewski, F., Khoury, M. P., Fernandes, K., Perrier, S., Bernard, H., Prats, A., Lane, D. P., & Bourdon, J. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.91 · Cited by 130 · see citing works

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial

Bonnefoi, H. R., Piccart, M. J., Bogaerts, J., Mauriac, L., Fumoleau, P., Brain, E. G. C., Petit, T., Rouanet, P., Jassem, J., Blot, E., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70094-8 · Cited by 128 · see citing works

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01012-6 · Cited by 126 · see citing works

Classic and novel roles of p53: prospects for anticancer therapy

Fuster, J. J., Sanz-Gonzalez, S. M., Moll, U. M., & Andrés, V. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.03.002 · Cited by 126 · see citing works

TAp73 regulates the spindle assembly checkpoint by modulating BubR1 activity

Tomasini, R., Tsuchihara, K., Tsuda, C., Lau, S. K., Wilhelm, M., Rufini, A., Tsao, M., Iovanna, J., Jurisicova, A., Melino, G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812096106 · Cited by 127 · see citing works

The impact of p53 and p73 on aneuploidy and cancer

Tomasini, R., Mak, T. W., & Melino, G. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.03.003 · Cited by 126 · see citing works

Small Molecular Weight Variants of p53 Are Expressed in Human Melanoma Cells and Are Induced by the DNA-Damaging Agent Cisplatin

Avery‐Kiejda, K. A., Zhang, X. D., Adams, L. J., Scott, R. J., Vojtěšek, B., Lane, D. P., & Hersey, P. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1422 · Cited by 122 · see citing works

p53: emerging roles in stem cells, development and beyond

Jain, A. K., & Barton, M. C. (2018) · Development · doi:10.1242/dev.158360 · Cited by 121 · see citing works

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study

Iacopetta, B. M., Russo, A. D., Bazan, V., Dardanoni, G., Gebbia, V., Soussi, T., Kerr, D. J., Elsaleh, H., Soong, R., Kandioler, D., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl035 · Cited by 119 · see citing works

DNA repair and aging: The impact of the p53 family

Nicolai, S., Rossi, A., Di Daniele, N., Melino, G., Annicchiarico-Petruzzelli, M., & Raschellà, G. (2015) · Aging · doi:10.18632/aging.100858 · Cited by 118 · see citing works

Genetic alterations in Krebs cycle and its impact on cancer pathogenesis

Sajnani, K., Islam, F., Smith, R. A., Gopalan, V., & Lam, A. K.-Y. (2017) · Biochimie · doi:10.1016/j.biochi.2017.02.008 · Cited by 116 · see citing works

Mechanisms of regulatory diversity within the p53 transcriptional network

Espinosa, J. M. (2008) · Oncogene · doi:10.1038/onc.2008.37 · Cited by 114 · see citing works

The p53 family in nervous system development and disease

Jacobs, W. B., Kaplan, D. R., & Miller, F. D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03980.x · Cited by 116 · see citing works

p53 downstream target genes and tumor suppression: a classical view in evolution

Rozan, L. M., & El‐Deiry, W. S. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402058 · Cited by 115 · see citing works

Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells

Vilgelm, A. E., Pawlikowski, J. S., Liu, Y., Hawkins, O. E., Davis, T. A., Smith, J., Weller, K. P., Horton, L. W., McClain, C. M., Ayers, G. D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2405 · Cited by 115 · see citing works

The Isoforms of the p53 Protein

Khoury, M. P., & Bourdon, J.-C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000927 · Cited by 191 · see citing works

p53 Isoforms as Modifiers of the p53-Dependent Responses: A Hidden Code?

Bartolomei, L., Pretto, B., Brugnara, S., Sontacchi, A., Dassi, V., Bousrih, A., Damaggio, C., Flangini, F., Bisio, A., & Ciribilli, Y. (2026) · Cancers · doi:10.3390/cancers18071057 · Cited by 2 · see citing works

P53 and cancer

Das, D. (2011)

p53: link to the past, bridge to the futurePreprint

Mills, A. A. (2005) · Genes & Development · doi:10.1101/gad.1362905 · Cited by 81 · see citing works

p53 Family Isoforms

Bourdon, J. (2007) · Current Pharmaceutical Biotechnology · doi:10.2174/138920107783018444 · Cited by 76 · see citing works